Thyroid cancer in older men

Aging Male

Volumn 14, Issue 2, 2011, Pages 91-98

  Rukhman, Natalya ^a   Silverberg, Alan ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

management; older men; risk factors; Thyroid cancer

Indexed keywords

CALCITONIN; CALCIUM; CARCINOEMBRYONIC ANTIGEN; CATECHOLAMINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; METADRENALIN; PREDNISONE; RADIOACTIVE IODINE; RITUXIMAB; THYROTROPIN; THYROXINE; VINCRISTINE;

ABLATION THERAPY; AGED; ANAPLASTIC CARCINOMA; ANAPLASTIC THYROID CANCER; CALCITONIN BLOOD LEVEL; CALCIUM BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CANCER THERAPY; DRUG DOSE REDUCTION; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LOBECTOMY; MALE; NECK DISSECTION; PRIMARY THYROID LYMPHOMA; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TRACHEOSTOMY; ULTRASOUND; WHOLE BODY SCINTISCANNING;

AGED; AGED, 80 AND OVER; AGING; CARCINOMA; HUMANS; MALE; THYROID NEOPLASMS;

EID: 79955704288     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685538.2010.529195     Document Type: Review

References (74)

1. Yancick R, Ries LA. Cancer in older persons. Cancer 1994;74:1995-2003.
2. Audisio RA, Repetta L, Zagonel V. Cancer in the elderly. In: Pollock RE, Doroshow JH, editors. UICC manual of clinical oncology. 8th ed. New Jersey: Wiley-Liss, 2004: (39):849-873.
3. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988- 2005. Cancer 2009;115:3801-3807.
4. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-2167.
5. Monganti S, Ceda GP, Saccani M, et al. Thyroid disease in the elderly: Sex-related differences in clinical expression. J Endocrinol Invest 2005;28(11 Suppl Proceedings):101-104.
6. Mazzaferri E.Management of a solitary thyroid nodule. NEJM 1993;328:553-559. (Pubitemid 23053833)
7. Schlumberger MJ, Filetti S, Hay ID. Nontoxic diffuse and nodular goiter and thyroid neoplasia. 11th ed. Kronenberg: Williams Textbook of Endocrinology; 2008. Chapter 13.
8. Frates MCFr, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB, Goellner GR, et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 2005;237:794-800. (Pubitemid 41636365)
9. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Toccogna S, Nardi F, Panunzi C, Rinaldi R, Toscano V, Pacella C. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002; 87:1941-1946. (Pubitemid 34521470)
10. Lin JD, Chao TC, Huang BY, Chen ST, Chang HY, Hsueh C. Thyroid cancer in the thyroid nodules evaluated by ultrasonagraphy and fine-needle aspiration cytology. Thyroid 2005;15:708-717. (Pubitemid 41117524)
11. Belfiore A, La Rosa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 1992;93:363-369.
12. Blum M, Rothschild M. Improved nonoperative diagnosis of the solitary "cold" thyroid nodule: surgical selection based on risk factors and three months of suppression. JAMA 1980; 243:242-245. (Pubitemid 10201604)
13. Welker MJ, Orlov D. Thyroid nodules. Am Fam Physician 2003;67:559-566.
14. Lin JD, Chao TC, Chen ST, Weng HF, Lin KD. Characteristics of thyroid carcinomas in aging patients. Eur J Clin Invest 2000;30:147-153. (Pubitemid 30079573)
15. Tuttle M, Leboeuf R, Martorella A. Papillary thyroid cancer: monitoring and therapy. Endocrinol Metab Clin 2007;36: 753-778. (Pubitemid 47135588)
16. Kilfoy BA, Devesa SS, Ward MH, Zhang Y, Rosenberg PS, Holford TR, Anderson WF. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev 2009;4: 1092-1100.
17. Arturi F, Russo D, Giuffrida D, Ippolito A , Perrotti N, Vigneri R , Filetti S. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 1997;82:1638-1641. (Pubitemid 27200449)
18. Qubain S.W, Nakano S, Baba M, Takao S, Aikou T. Distribution of lymph node micrometastasis in pN0 welldifferentiated thyroid carcinoma. Surgery 2002;131:249-256. (Pubitemid 34229777)
19. McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986;61:978-996. (Pubitemid 17205209)
20. Sebastian SO, Gonzalez JM, Paricio SP, Perez S, Flores P, Madrona P, Romero RP, Tebar FJ. Papillary thyroid carcinoma: prognostic index for survival including the histological variety. Arch Surg 2000;135:272-277. (Pubitemid 30154566)
21. Mazaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol 1987;14;315-332.
22. Goldballe C, Asschenfeld P, Sorensen JA, Sorensen MW, Jorgensen K. Papillary thyroid carcinoma: correlations between prognosis, age, and clinicopathological and histomorphological findings. Laryngoscope 1994;104: 747-751. (Pubitemid 24174216)
23. Sautter-Bihl M, Raub J, Hetzel-Sesterheim M, Heinze HG. Differentiated thyroid cancer. Prognostic factors and influence of treatment on the outcome in 441 patients. Strahlenther Onkol 2001;177:125-131. (Pubitemid 32220421)
24. Hawk WA, Hazzard JB. The many appearances of papillary carcinoma of the thyroid. Clev Clin Q 1976;43:207-216. (Pubitemid 8013660)
25. Machens A, Hauptmann S, Dralle H. Disparities between male and female patients with thyroid cancers: sex difference or gender divide? Clin Endocrinol 2006;65:500-505. (Pubitemid 44414274)
26. Levi F, Randimbison L, Te VC, La Vecchia C. Thyroid cancer in Vaud, Switzerland: an update. Thyroid 2002;12:163-167.
27. Mazzaferri E, Lhiang S. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-428. (Pubitemid 24345593)
28. Correra P, Chen VW. Endocrine gland cancer. Cancer 1995;75(Suppl):338- 352.
29. Gupta KL. Neoplasm of the thyroid gland. Clin Geriatr Med 1995;11:271-290.
30. Grebe SKG, Hay ID. Follicular thyroid cancer. Endocrinol Metab Clin North Am 1996;24:761-801.
31. Phitayakorn R, Mchenry C. Follicular and Hurthle cell carcinoma of the thyroid gland. Surg Oncol Clin N Am 2006;15:603-623. (Pubitemid 44119214)
32. Woolner LB. Thyroid carcinoma: pathologic classification with data on prognosis. Semin Nucl Med 1971;1:481-502.
33. Schneider AB, Sarne DH. Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Natl Clin Pract Endocrinol Metab 2005;1:82.
34. Mazzaferri E. Thyroid Cancer. Principles and practice of endocrinology and metabolism. 3rd ed, 2001. Chapter 40, Lippincott Williams and Wilkins, Philadelphia.
35. Tuttle M, Lemar H, Burch H. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 1998;8: 377-383. (Pubitemid 28252418)
36. Crile G, Pontius KI, Hawk WA. Factors influencing the survival of patients with follicular carcinoma of the thyroid gland. Surg Gynecol Obstet 1985;160:409-413. (Pubitemid 15057832)
37. Brandi ML, Gagel RF, Angeli A, Bilezikean JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86:5658-5671. (Pubitemid 33152604)
38. Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 2000;88:1139-1148. (Pubitemid 30127676)
39. Sherman Steven. Thyroid carcinoma. Lancet 2003;361:501-511.
40. Elisei R, Bottici V, Luchetti F, Coscio G, Romei C, Grasso L, Miccoli P, Iaconni P, Basolo F, Pinchera A. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 2004;89:163-168. (Pubitemid 38183876)
41. Hahm JR, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ, Yang JH, Chung JH. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 2001;11:73-80. (Pubitemid 32140448)
42. Redding AH, Levine SN, Fowler MR. Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. Thyroid 2000;10:919-922.
43. Saad MF, Ordonez NG, Rashid RK, Guido JJ, Hill SC, Hickey RC, Samaan NA. Medullary carcinoma of the thyroid. Medicine 1984;63:319-342.
44. Scopsi L, Sampietro G, Boracchi P, Del Bo R, Gullo M, Placucci M, Pilotti S. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients. Cancer 1996;78:2173-2183. (Pubitemid 26367612)
45. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer 1998;83:2638-2648. (Pubitemid 29019586)
46. Are C, Shaha AR. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 2006;13:453-464.
47. Hadar T, Mor C, Shvero J, Levy R, Segal K. Anaplastic carcinoma of the thyroid. Eur J Surg Oncol 1993;19:511-516. (Pubitemid 24024594)
48. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 1997;79:564-573. (Pubitemid 27051783)
49. Ain KB. Anaplastic thyroid carcinoma: a therapeutic challenge. Semin Surg Oncol 1999;16:64-69.
50. Giuffrida D, Gharib H. Anaplastic thyroid carcinoma: current diagnosis and treatment. Ann Oncol 2000;11:1083-1089.
51. Haigh PI, Ituarte PH, Wu HS, Treseler PA, Posner MD, Quivey JM, Duh QY, Clark OH. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 2001;91:2335-2342. (Pubitemid 32552820)
52. Kim TY, Kim KW, Jung TS, Kim JM, Kim SW, Chung K, Kim EY, Gong G, OH YL, Cho SY, et al. Prognostic factors for Korean patients with anaplastic thyroid carcinoma. Head Neck 2007;29:765-772. (Pubitemid 47265532)
53. Pierie JP, Muzikansky A, Gaz RD, Faquin WC, Ott MJ. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol 2002;9:57-64. (Pubitemid 34262898)
54. Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A. Anaplastic thyroid carcinoma treatment outcome and prognostic factors. Cancer 2005;103:1330-1335. (Pubitemid 40410726)
55. Tan RK, Finley RK, Driscoll D, Bakamjian V, Hicks WL, Shedd DP. Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck 1995;17:41-47.
56. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg 2001;25:617-622. (Pubitemid 32441436)
57. Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. Semin Oncol 1999;26:316-323. (Pubitemid 29272899)
58. Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Hefess CS, Abbondanzo SL. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol 2000;24:623-639. (Pubitemid 30253500)
59. Belal AA, Allam A, Kandil A, Husseiny G, Khafaga Y, Rajhi A, Ahmed G, Gray A, Ajarim D, Schultz H. Primary thyroid lymphoma: a retrospective analysis of prognostic factors and treatment outcome for localized intermediate and high grade lymphoma. Am J Clin Oncol 2001;24:299-305. (Pubitemid 32520640)
60. Graff-Baker A, Sosa JA, Roman SA. Primary thyroid lymphoma: a review of recent developments in diagnosis and histology-driven treatment. Curr Opin Oncol 2010;22:17-22.
61. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Eng J Med 1985;312:601-604. (Pubitemid 15133674)
62. Hwang YC, Kim TY, Kim WB, Shong YK, Yi KH, Shong M, Jo YS, Kim WS, Chung JH. Clinical characteristics of primary thyroid lymphoma in Koreans. Endocr J 2009;56:399-405.
63. Graff-Baker A, Roman SA, Thomas DC, Udelsman R, Sosa JA. Prognosis of primary thyroid lymphoma: demographic, clinical and pathologic predictors of survival in 1,408 cases. Surgery 2009;146: 1105-1115.
64. Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447-1463. (Pubitemid 32374886)
65. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. European consensus for the management of patients with differentiated thyroid cancer of the follicular epithelium. Eur J Endocrinol 2006;154:783-803.
66. Cooper D, Doherty G, Haugen B, et al. Revised thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19: 1167-1214.
67. Mazzaferri EL, Jhiang SM. Differentiated thyroid cancer longterm impact of initial therapy. Trans Am Clin Climatol Assoc 1994;106:151-168.
68. Samaan NA, Shultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin EndocrinolMetab 1992;75:714-720.
69. Sawka AM, Brierley JD, Tsang RW, et al. An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 2008;37:457-480. (Pubitemid 351711675)
70. Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006;295:1033-1041.
71. Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009;19:565-612.
72. Brierley J, Tsang R, Simpson WJ, et al. Medullary thyroid cancer: analysis of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 1996;6:305-310. (Pubitemid 26303135)
73. Neff RL, Farrar WB, Kloos RT. Anaplastic thyroid cancer. Endocrinol Metab Clin N Am 2008;37:525-538. (Pubitemid 351711678)
74. Pfreundschuh M, Schubert J, Ziepert M, et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol 2008;9:105-116.